Status:
COMPLETED
Quantitative Fluorescent Guided Robotic Surgery for Cancer of the Gastroesophageal Junction
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Stomach Neoplasms
Surgery
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators also aim to use our previously described quantifying method (q-ICG), to evaluate changes in gastric perfusion, during resection of cancer in the gastroesophageal junction (GEJ) and i...
Detailed Description
2\. Introduction 2.1 Adenocarcinoma of the gastroesophageal tract Adenocarcinoma of the gastroesophageal tract, including the esophagus, stomach, and gastroesophageal junction (GEJ) is a growing clin...
Eligibility Criteria
Inclusion
- Patients (above 18 years) scheduled for planned open or robot-assisted resection of gastroesophageal junction cancer.
Exclusion
- Allergy towards; iodine, indocyanine green or shellfish
- Severe liver insufficiency
- Thyrotoxicosis
- Nephropathy requiring dialysis
- Pregnancy or lactation
- Legally incompetent for any reason
- Withdrawal of inclusion consent at any time
Key Trial Info
Start Date :
June 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 13 2021
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04107623
Start Date
June 16 2020
End Date
October 13 2021
Last Update
October 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, Denmark, 2100